[EFFECT] Medicus Pharma Ltd. SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

03/30/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 27, 2026

Accession Number:

0001062993-26-001617

Submission Type:

POS AM

CIK:	0001997296
Company Name:	Medicus Pharma Ltd.
File Number:	333-287599

Source: View Original Filing on SEC EDGAR

Medicus Pharma Ltd

NASDAQ:MDCX

View MDCX Stock Overview →

MDCX Rankings

#6280 Ranked by Market Cap

N/A Ranked by Dividends

#139 Top Loser

MDCX Latest News

Mar 30, 2026

Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate

Mar 26, 2026

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Mar 25, 2026

Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update

Mar 18, 2026

Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

Mar 16, 2026

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

MDCX Latest SEC Filings

Mar 30, 2026

[EFFECT] Medicus Pharma Ltd. SEC Filing

Mar 25, 2026

[POS AM] Medicus Pharma Ltd. SEC Filing

Mar 25, 2026

[POS AM] Medicus Pharma Ltd. SEC Filing

Mar 25, 2026

[POS AM] Medicus Pharma Ltd. SEC Filing

Mar 25, 2026

[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)

MDCX Stock Data

Market Cap 13.85M

Float 17.84M

Industry Drug Manufacturers - General

Sector Pharmaceutical Preparations

Website Link

Country United States

City W. CONSHOHOCKEN